Published in J Clin Invest on July 15, 1996
Pathology of pulmonary hypertension. Clin Chest Med (2007) 2.34
Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am J Pathol (1997) 1.64
Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol (1997) 1.22
Development of occlusive neointimal lesions in distal pulmonary arteries of endothelin B receptor-deficient rats: a new model of severe pulmonary arterial hypertension. Circulation (2005) 1.04
Vascular remodeling in pulmonary hypertension. J Mol Med (Berl) (2013) 1.02
Physiologic changes in a nonhuman primate model of HIV-associated pulmonary arterial hypertension. Am J Respir Cell Mol Biol (2012) 0.97
Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension. Respir Res (2011) 0.95
The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes. Am J Physiol Lung Cell Mol Physiol (2014) 0.94
Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstriction. J Pharmacol Toxicol Methods (2011) 0.83
Monocrotaline pyrrole induces Smad nuclear accumulation and altered signaling expression in human pulmonary arterial endothelial cells. Vascul Pharmacol (2007) 0.79
Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation. Compr Physiol (2011) 0.75
Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med (1993) 4.91
The emerging concept of vascular remodeling. N Engl J Med (1994) 4.27
Mechanisms of stenosis after arterial injury. Lab Invest (1983) 3.75
Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med (1995) 3.70
Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest (1995) 2.30
The structure of the pulmonary trunk at different ages and in cases of pulmonary hypertension and pulmonary stenosis. J Pathol Bacteriol (1959) 2.21
Regional heterogeneity of elastin and collagen gene expression in intralobar arteries in response to hypoxic pulmonary hypertension as demonstrated by in situ hybridization. Am J Pathol (1989) 2.02
Simplified rat lung transplantation using a cuff technique. J Thorac Cardiovasc Surg (1989) 1.94
Smooth muscle cell to elastic lamina connections in developing mouse aorta. Role in aortic medial organization. Lab Invest (1993) 1.64
Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension. Am J Physiol (1988) 1.57
Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis (1990) 1.49
Severe pulmonary hypertension and arterial adventitial changes in newborn calves at 4,300 m. J Appl Physiol (1985) (1987) 1.40
Vascular remodeling in primary pulmonary hypertension. Potential role for transforming growth factor-beta. Am J Pathol (1994) 1.32
Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am J Pathol (1994) 1.32
Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries. Am J Pathol (1992) 1.25
Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline-treated rats. Microvasc Res (1989) 1.23
Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline. A biochemical and ultrastructural study. Lab Invest (1988) 1.17
Collagen and elastin metabolism in hypertensive pulmonary arteries of rats. Circ Res (1990) 1.17
Pathological changes in rats as a result of treatment with monocrotaline. Br J Cancer (1955) 1.16
The relation of age and blood pressure to atheroma in the pulmonary arteries and thoracic aorta in congenital heart disease. Lab Invest (1960) 1.15
Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry. Am J Pathol (1993) 1.15
Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension. Am J Physiol (1985) 1.06
Active collagen synthesis by pulmonary arteries in human primary pulmonary hypertension. Am J Pathol (1993) 1.04
Transforming growth factor-beta 1 is decreased in remodeling hypertensive bovine pulmonary arteries. J Clin Invest (1992) 1.01
Pressure-induced connective tissue synthesis in pulmonary artery segments is dependent on intact endothelium. J Clin Invest (1989) 1.01
Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries. J Clin Invest (1993) 0.99
A new in vitro system for studying cell response to mechanical stimulation. Different effects of cyclic stretching and agitation on smooth muscle cell biosynthesis. Exp Cell Res (1977) 0.97
Increased pulmonary artery elastolytic activity in adult rats with monocrotaline-induced progressive hypertensive pulmonary vascular disease compared with infant rats with nonprogressive disease. Am Rev Respir Dis (1992) 0.97
Oxygen toxicity and restructuring of pulmonary arteries--a morphometric study. The response to 4 weeks' exposure to hyperoxia and return to breathing air. Am J Pathol (1985) 0.96
Sequence of structural changes and elastin peptide release during vascular remodelling in sheep with chronic pulmonary hypertension induced by air embolization. Am J Pathol (1991) 0.93
Effect of mechanical forces on growth and matrix protein synthesis in the in vitro pulmonary artery. Analysis of the role of individual cell types. Circ Res (1995) 0.92
Temporal alterations in specific basement membrane components in lungs from monocrotaline-treated rats. Am J Respir Cell Mol Biol (1993) 0.90
Active macrophage-associated TGF-beta co-localizes with type I procollagen gene expression in atherosclerotic human pulmonary arteries. Am J Pathol (1995) 0.89
Increase of collagen synthesis in pulmonary arteries of monocrotaline-treated rats. Experientia (1980) 0.83
Effect of a mixed function oxidase inducer and inhibitor on monocrotaline pyrrole pneumotoxicity. Toxicol Appl Pharmacol (1986) 0.80
Significance of the relatively low incidence of atherosclerosis in the pulmonary, renal, and mesenteric arteries. Ann N Y Acad Sci (1968) 0.79
The acute respiratory distress syndrome. N Engl J Med (1995) 5.24
Defective angiogenesis in mice lacking endoglin. Science (1999) 4.40
Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am Rev Respir Dis (1992) 3.64
Elastin is an essential determinant of arterial morphogenesis. Nature (1998) 3.56
Results of single-lung transplantation for bilateral pulmonary fibrosis. The Toronto Lung Transplant Group. N Engl J Med (1990) 2.85
A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant (1993) 2.69
Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome. Sci Transl Med (2010) 2.55
Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest (1995) 2.53
Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg (1995) 2.44
Novel arterial pathology in mice and humans hemizygous for elastin. J Clin Invest (1998) 2.41
A mouse model of orthotopic vascularized aerated lung transplantation. Am J Transplant (2007) 2.16
Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg (1996) 2.15
Criteria for outpatient management of proximal lower extremity deep venous thrombosis. Chest (1999) 2.06
Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices. J Cell Biol (1994) 2.03
Fluid balance during pulmonary edema. Is fluid gain a marker or a cause of poor outcome? Chest (1991) 2.03
Clinical evaluation compared to pulmonary artery catheterization in the hemodynamic assessment of critically ill patients. Crit Care Med (1984) 1.76
Ethnic differences in secretion, sensitivity, and hepatic extraction of insulin in black and white Americans. Diabet Med (1994) 1.67
CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant (2006) 1.63
The current role of mediastinoscopy in the evaluation of thoracic disease. J Thorac Cardiovasc Surg (1999) 1.59
Donor lung procurement: assessment and operative technique. Ann Thorac Surg (1993) 1.54
Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg (1987) 1.54
A prospective study of lung water measurements during patient management in an intensive care unit. Am Rev Respir Dis (1987) 1.52
Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung. J Thorac Cardiovasc Surg (1986) 1.47
Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: a ten-year institutional experience. J Thorac Cardiovasc Surg (2000) 1.46
Is there ever a role for salvage operations in limited small-cell lung cancer? J Thorac Cardiovasc Surg (1991) 1.46
Outcome of Medicare patients with emphysema selected for, but denied, a lung volume reduction operation. Ann Thorac Surg (1998) 1.45
Single lung transplantation and closure of patent ductus arteriosus for Eisenmenger's syndrome. Toronto Lung Transplant Group. J Thorac Cardiovasc Surg (1990) 1.42
Bovine latent transforming growth factor beta 1-binding protein 2: molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils. Mol Cell Biol (1995) 1.42
Inducible nitric oxide synthase is expressed during experimental acute lung allograft rejection. J Heart Lung Transplant (1997) 1.41
Ventilator-associated pneumonia: clinical considerations. AJR Am J Roentgenol (1994) 1.41
HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation (1998) 1.41
Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol (1997) 1.40
Preharvest nitroprusside flush improves posttransplantation lung function. J Heart Lung Transplant (1997) 1.40
Strategies to increase limited donor resources. Eur Respir J (2004) 1.38
Separate extraction of cardiac and pulmonary grafts from a single organ donor. Ann Thorac Surg (1988) 1.37
Precedents for meaningful recovery during treatment in a medical intensive care unit. Outcome in patients with hematologic malignancy. Am J Med (1983) 1.33
Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation (1999) 1.28
Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Transplant (2005) 1.27
Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg (1998) 1.26
Developmental regulation of FKBP65. An ER-localized extracellular matrix binding-protein. Mol Biol Cell (2000) 1.25
Double-lung transplant for advanced chronic obstructive lung disease. Am Rev Respir Dis (1989) 1.23
Evaluation of suicidal patients: the SAD PERSONS scale. Psychosomatics (1983) 1.22
Pulmonary hemodynamics modify the rat pulmonary artery response to injury. A neointimal model of pulmonary hypertension. Am J Pathol (1997) 1.22
Smoking cessation and lung cancer resection. Chest (1996) 1.21
Isolated supravalvular aortic stenosis: functional haploinsufficiency of the elastin gene as a result of nonsense-mediated decay. Hum Genet (2000) 1.20
Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome. Am J Transplant (2008) 1.19
Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation. Am J Transplant (2012) 1.19
Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg (1997) 1.18
Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med (1984) 1.18
Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequences on the long arm of chromosome 4. Cancer Res (1996) 1.17
CCR2 regulates monocyte recruitment as well as CD4 T1 allorecognition after lung transplantation. Am J Transplant (2010) 1.17
Supradiaphragmatic ligation of the thoracic duct in intractable chylous fistula. Ann Thorac Surg (1981) 1.17
Prophylactic therapy for stress ulcer bleeding: a reappraisal. Ann Intern Med (1987) 1.15
Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Ann Thorac Surg (1995) 1.15
Pulmonary artery aneurysm: review and case report. Clin Cardiol (1995) 1.14
Results of transcervical thymectomy for myasthenia gravis in 100 consecutive patients. Ann Surg (1999) 1.14
In vitro generation of scaffold independent neocartilage. Clin Orthop Relat Res (2001) 1.13
Surgeons' concern and practices of protection against bloodborne pathogens. Ann Surg (1998) 1.12
Experiences of women in cardiothoracic surgery. A gender comparison. Arch Surg (1996) 1.11
Comparison of early functional results after volume reduction or lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg (1996) 1.10
Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg (1995) 1.10
Role of cyclooxygenase-2 in oleic acid-induced acute lung injury. Am J Respir Crit Care Med (1999) 1.08
Bilateral lung transplantation for cystic fibrosis. The Toronto Lung Transplant Group. J Thorac Cardiovasc Surg (1992) 1.08
Redo lung transplantation: a North American-European experience. J Heart Lung Transplant (1993) 1.08
Use of silicone stents in the management of airway problems. Ann Thorac Surg (1989) 1.08
Evaluation of a prototype esophageal detection device. Acad Emerg Med (1995) 1.07
Ex vivo adenoviral-mediated gene transfer to lung isografts during cold preservation. Ann Thorac Surg (1997) 1.07
Bronchial dehiscence in lung transplantation: CT evaluation. Radiology (1995) 1.07
Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Transplantation (1999) 1.04
Fibrillin-1 and fibrillin-2 show temporal and tissue-specific regulation of expression in developing elastic tissues. Connect Tissue Res (1995) 1.04
The value of adjuvant radiotherapy in pulmonary and chest wall resection for bronchogenic carcinoma. Ann Thorac Surg (1982) 1.02
A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings. J Thorac Cardiovasc Surg (2005) 1.02
Preoperative prediction for the use of cardiopulmonary bypass in lung transplantation. J Thorac Cardiovasc Surg (1993) 1.02
A comparative study of thoracoscopic vs open removal of benign neurogenic mediastinal tumors. Chest (1996) 1.01
Early metabolic improvement following bariatric surgery in morbidly obese adolescents. Pediatr Blood Cancer (2011) 1.01
Differential expression of two tropoelastin genes in zebrafish. Matrix Biol (2006) 1.01
Temporal relationship between the development of anti-HLA antibodies and the development of bronchiolitis obliterans syndrome after lung transplantation. Transplant Proc (1999) 1.00
Sphingosine 1-phosphate inhibits ischemia reperfusion injury following experimental lung transplantation. Am J Transplant (2007) 1.00
Major histocompatibility complex expression and lung ischemia-reperfusion in rats. Ann Thorac Surg (1996) 1.00
Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Am J Transplant (2001) 1.00
Favorable results after sleeve lobectomy or bronchoplasty for bronchial malignancies. Ann Thorac Surg (1999) 1.00
A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study. J Thorac Cardiovasc Surg (1989) 0.99
Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg (1996) 0.99
Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries. J Clin Invest (1993) 0.99
Precision cautery excision of pulmonary lesions. Ann Thorac Surg (1986) 0.97
Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation. Am J Respir Crit Care Med (1998) 0.97
Single lung transplantation for pulmonary hypertension. Single institution experience in 34 patients. Circulation (1995) 0.97
Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness. Diabetes Care (1997) 0.97
Clinical-pathologic analysis of 40 patients with large cell neuroendocrine carcinoma of the lung. Ann Thorac Surg (1997) 0.97
The role of caveolin-1 in pulmonary matrix remodeling and mechanical properties. Am J Physiol Lung Cell Mol Physiol (2008) 0.96
Results of single and bilateral lung transplantation in 131 consecutive recipients. Washington University Lung Transplant Group. J Thorac Cardiovasc Surg (1994) 0.95
Lung transplantation: a decade of experience. Ann Surg (1999) 0.95
Activation of human airway epithelial cells by non-HLA antibodies developed after lung transplantation: a potential etiological factor for bronchiolitis obliterans syndrome. Transplantation (2001) 0.95
Complete foregut duplication. Ann Thorac Surg (1990) 0.95
Imaging the spatial distribution of transgene expression in the lungs with positron emission tomography. Gene Ther (2003) 0.95
Airway revascularization: is it necessary? Ann Thorac Surg (1993) 0.94
Inhibition of tropoelastin expression by 1,25-dihydroxyvitamin D3. Connect Tissue Res (1991) 0.94